homovanillic acid has been researched along with olanzapine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (77.78) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gispen-de Wied, CC; Kahn, RS; Scheepers, FE; Westenberg, HG | 1 |
Altar, CA; Dunn, R; Jordan, S; Kikuchi, T; Koprivica, V; Tottori, K | 1 |
Adamson, B; Arjona, AA; Wurtman, RJ; Zhang, SX | 1 |
Anguiano, JB; Arrúe, A; Basterreche, N; Dávila, R; Zamalloa, MI; Zumárraga, M | 1 |
Hori, H; Ida, Y; Ikenouchi, A; Mitoma, M; Nakamura, J; Yamada, Y; Yoshimura, R | 1 |
Bondi, E; Borriello, R; Brambilla, F; Daga, GA; Fassino, S; Favaro, A; Garcia, CS; Mellado, C; Monteleone, P; Ramaciotti, C; Santonastaso, P | 1 |
Arrue, A; Basterreche, N; Dávila, R; Goienetxea, B; González-Torres, MA; Guimón, J; Zumárraga, M | 1 |
Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
Amianto, F; Brambilla, F; Dalle Grave, R; Fassino, S | 1 |
5 trial(s) available for homovanillic acid and olanzapine
Article | Year |
---|---|
The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Olanzapine; Pirenzepine; Schizophrenia | 2001 |
Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Catecholamines; Cytokines; Female; Homovanillic Acid; Humans; Interleukin-2; Interleukin-6; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Olanzapine therapy in anorexia nervosa: psychobiological effects.
Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Dopamine Antagonists; Double-Blind Method; Female; Homovanillic Acid; Humans; Olanzapine | 2007 |
Plasma homovanillic acid and family history of psychotic disorders in bipolar I patients.
Topics: Adult; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Family Health; Female; Homovanillic Acid; Humans; Lithium Compounds; Male; Olanzapine; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background.
Topics: Administration, Oral; Adult; Analysis of Variance; Anorexia Nervosa; Antipsychotic Agents; Benzodiazepines; Bulimia Nervosa; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Olanzapine; Paroxetine; Psychotherapy, Brief; Serotonin Plasma Membrane Transport Proteins; Treatment Failure | 2014 |
4 other study(ies) available for homovanillic acid and olanzapine
Article | Year |
---|---|
In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebral Cortex; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Neostriatum; Olanzapine; Piperazines; Prefrontal Cortex; Quinolones; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin | 2004 |
An animal model of antipsychotic-induced weight gain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Body Weight; Brain Chemistry; Chromatography, High Pressure Liquid; Darkness; Dopamine; Eating; Electrochemistry; Female; Food Preferences; Homovanillic Acid; Hydroxyindoleacetic Acid; Models, Animal; Motor Activity; Olanzapine; Photoperiod; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors; Weight Gain | 2004 |
Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biogenic Monoamines; Bipolar Disorder; Catechol O-Methyltransferase; Drug Therapy, Combination; Female; Gene Expression; Genetic Predisposition to Disease; Genotype; Homovanillic Acid; Humans; Lithium Carbonate; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Polymorphism, Genetic; Prevalence; Psychotic Disorders; Severity of Illness Index; Treatment Outcome | 2006 |
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Female; Homovanillic Acid; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Young Adult | 2010 |